| Negative Results: Relaxin ® Clinical Trials for Scleroderma |
| Phase III Relaxin Trial Did Not Reach Primary Endpoint. Relaxin is of no value for the treatment of scleroderma. |
| "Scleroderma has again proven to be an extremely difficult disease for which to develop a therapeutic treatment." Connetics 10-8-00. |
| Related Links |
| Scleroderma Research Registries. ISN. |
| Scleroderma Treatments & Clinical Trials. ISN. |
| Ineffective or Unproven Treatments for Scleroderma. ISN. |
 SCLERO.ORG |
|||||||||||||||||||||||
|
| | ||||||||
| Keep on Surfing! | ||||||||
| Go to Scleroderma Clinical Trials: Positive Results | ||||||||
| ||||||||
| Thanks to Actelion |
 |
| In Loving Memory |
| Donate in Memory |
| Tackling Scleroderma! |
| Recent donors or purchasers of ISN and SCLERO.ORG items: |
| Donate or Shop Now |
| Running for SCLERO.ORG! |
 |
| Sponsor Earl Manns in Chicago Marathon, October 12, 2008! I'm running in honor of my daughter Mya, and in memory of Sherrill Knaggs. (Also see Donate Now and Earl Manns) |